21 CFR PART 510 - ADVERSE DRUG REACTION, LACK OF EFFECTIVENESS, PRODUCT DEFECT REPORT

ICR 198705-0910-002

OMB: 0910-0012

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
ICR Details
0910-0012 198705-0910-002
Historical Active 198403-0910-006
HHS/FDA
21 CFR PART 510 - ADVERSE DRUG REACTION, LACK OF EFFECTIVENESS, PRODUCT DEFECT REPORT
Revision of a currently approved collection   No
Regular
Approved without change 06/24/1987
Retrieve Notice of Action (NOA) 05/05/1987
THE BURDEN HOUR JUSTIFICATION IS INACCURATE AND SHOULD BE REVISED TO INDICATE THAT THE ESTIMATED HOURS PER RESPONSE HAVE ALSO CHANGED.
  Inventory as of this Action Requested Previously Approved
06/30/1990 06/30/1990 07/31/1987
1,000 0 750
1,200 0 260
0 0 0

INFORMATION IS GATHERED BY CVM FROM MANUFACTURERS OF ANIMAL DRUG PRODUCTS AND VETERINARIANS ON ADVERSE DRUG REACTIONSON NEW ANIMAL DRUGS. THIS REGULATION REQUIRE THE SUBMISSION OF FULL REPORTS OF INFORMATION PERTINENT TO THE SAFETY EFFECTIVENESS OF THE NEW ANIMAL DRUG.

None
None


No

1
IC Title Form No. Form Name
21 CFR PART 510 - ADVERSE DRUG REACTION, LACK OF EFFECTIVENESS, PRODUCT DEFECT REPORT FDA 1932 &, 1932A

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 1,000 750 0 33 217 0
Annual Time Burden (Hours) 1,200 260 0 125 815 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
05/05/1987


© 2024 OMB.report | Privacy Policy